Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 5,159 | 7,320 | 6,130 | 7,710 | 6,433 |
| Operating Income | -5,159 | -7,320 | -6,130 | -7,710 | -6,433 |
| Interest Expense | 3 | 6 | 9 | 205 | 159 |
| Other Income | 178 | 136 | 177 | 5 | -44 |
| Pre-tax Income | -4,984 | -7,190 | -5,962 | -7,910 | -6,636 |
| Income Tax | N/A | -3,226 | -2,414 | -5,888 | N/A |
| Net Income Continuous | -4,984 | -3,965 | -3,548 | -2,022 | -6,636 |
| Net Income Discontinuous | N/A | 1,069 | N/A | 40,487 | -3,158 |
| Minority Interests | -2 | 56 | -119 | -254 | -434 |
| Net Income | $-4,982 | $-2,952 | $-3,428 | $38,719 | $-9,360 |
| EPS Basic Total Ops | -7.80 | -4.20 | -5.70 | 65.07 | -16.79 |
| EPS Basic Continuous Ops | -7.82 | -6.00 | -5.70 | -3.30 | -11.69 |
| EPS Basic Discontinuous Ops | N/A | 1.65 | N/A | 68.37 | -4.95 |
| EPS Diluted Total Ops | -7.80 | -4.20 | -5.70 | 65.07 | -16.79 |
| EPS Diluted Continuous Ops | -7.82 | -6.00 | -5.70 | -3.30 | -11.69 |
| EPS Diluted Discontinuous Ops | N/A | 1.65 | N/A | 68.37 | -4.95 |
| EBITDA(a) | $-4,990 | $-7,111 | $-5,860 | $-7,576 | $-6,334 |